Maze Therapeutics, Inc.

MAZE · XNAS

CIK 1842295fmd_0PRN2Y3XCV4N3WSPWJHRMWCHNNManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2024 to Sep 30, 2026, 11 periods

Ratios computed from the standardized statements. Select a value to open its proof.